Cargando…

Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya

BACKGROUND: Pediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and HIV drug resistance (HIVDR) are challenges to achieving UNAIDS’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression. In Kenya,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilgrim, Nanlesta A., Okal, Jerry, Matheka, James, Mukui, Irene, Kalibala, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060498/
https://www.ncbi.nlm.nih.gov/pubmed/30045700
http://dx.doi.org/10.1186/s12887-018-1209-5
_version_ 1783342043411513344
author Pilgrim, Nanlesta A.
Okal, Jerry
Matheka, James
Mukui, Irene
Kalibala, Samuel
author_facet Pilgrim, Nanlesta A.
Okal, Jerry
Matheka, James
Mukui, Irene
Kalibala, Samuel
author_sort Pilgrim, Nanlesta A.
collection PubMed
description BACKGROUND: Pediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and HIV drug resistance (HIVDR) are challenges to achieving UNAIDS’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression. In Kenya, the pediatric population represents 8% of total HIV infections and pediatric virological failure is estimated at 33%. The monitoring of early warning indicators (EWIs) for HIVDR can help to identify and correct gaps in ART program functioning to improve HIV care and treatment outcomes. However, EWIs have not been integrated into health systems. We assessed challenges to the use of EWIs and solutions to challenges identified by frontline health administrators. METHODS: We conducted key informant interviews with health administrators who were fully knowledgeable of the ART program at 23 pediatric ART sites in 18 counties across Kenya from May to June 2015. Thematic content analysis identified themes for three EWIs: on-time pill pick-up, retention in care, and virological suppression. RESULTS: Nine themes—six at the facility level and three at the patient level—emerged as major challenges to EWI monitoring. At the facility level, themes centered on system issues (e.g., slow return of viral load results), staff shortages and inadequate adherence counseling skills, lack of effective patient tracking and linkage systems, and lack of support for health personnel. At the patient level, themes focused on stigma, non-disclosure of HIV status to children who are age eligible, and little engagement of guardians in the children’s care. Practical solutions identified included the use of lay health workers (e.g., peer educators, community health workers) to implement a variety of care and treatment tasks, whole facility approaches to adherence counseling, adolescent peer support groups, and working with children directly as soon as they are age eligible. DISCUSSION: The monitoring of EWIs has not been routine in health facilities in Kenya due to several challenges. However, facilities have implemented novel strategies to address some of these barriers. Future work is needed to assess whether scale-up of some of these approaches can aid in the effective use of EWIs and improving HIV care outcomes among the pediatric population.
format Online
Article
Text
id pubmed-6060498
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60604982018-07-31 Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya Pilgrim, Nanlesta A. Okal, Jerry Matheka, James Mukui, Irene Kalibala, Samuel BMC Pediatr Research Article BACKGROUND: Pediatric non-adherence to antiretroviral therapy (ART), loss to follow-up, and HIV drug resistance (HIVDR) are challenges to achieving UNAIDS’ targets of 90% of those diagnosed HIV-positive receiving treatment, and 90% of those receiving treatment achieving viral suppression. In Kenya, the pediatric population represents 8% of total HIV infections and pediatric virological failure is estimated at 33%. The monitoring of early warning indicators (EWIs) for HIVDR can help to identify and correct gaps in ART program functioning to improve HIV care and treatment outcomes. However, EWIs have not been integrated into health systems. We assessed challenges to the use of EWIs and solutions to challenges identified by frontline health administrators. METHODS: We conducted key informant interviews with health administrators who were fully knowledgeable of the ART program at 23 pediatric ART sites in 18 counties across Kenya from May to June 2015. Thematic content analysis identified themes for three EWIs: on-time pill pick-up, retention in care, and virological suppression. RESULTS: Nine themes—six at the facility level and three at the patient level—emerged as major challenges to EWI monitoring. At the facility level, themes centered on system issues (e.g., slow return of viral load results), staff shortages and inadequate adherence counseling skills, lack of effective patient tracking and linkage systems, and lack of support for health personnel. At the patient level, themes focused on stigma, non-disclosure of HIV status to children who are age eligible, and little engagement of guardians in the children’s care. Practical solutions identified included the use of lay health workers (e.g., peer educators, community health workers) to implement a variety of care and treatment tasks, whole facility approaches to adherence counseling, adolescent peer support groups, and working with children directly as soon as they are age eligible. DISCUSSION: The monitoring of EWIs has not been routine in health facilities in Kenya due to several challenges. However, facilities have implemented novel strategies to address some of these barriers. Future work is needed to assess whether scale-up of some of these approaches can aid in the effective use of EWIs and improving HIV care outcomes among the pediatric population. BioMed Central 2018-07-25 /pmc/articles/PMC6060498/ /pubmed/30045700 http://dx.doi.org/10.1186/s12887-018-1209-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pilgrim, Nanlesta A.
Okal, Jerry
Matheka, James
Mukui, Irene
Kalibala, Samuel
Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
title Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
title_full Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
title_fullStr Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
title_full_unstemmed Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
title_short Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya
title_sort challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric hiv drug resistance in kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060498/
https://www.ncbi.nlm.nih.gov/pubmed/30045700
http://dx.doi.org/10.1186/s12887-018-1209-5
work_keys_str_mv AT pilgrimnanlestaa challengestoandopportunitiesfortheadoptionandroutineuseofearlywarningindicatorstomonitorpediatrichivdrugresistanceinkenya
AT okaljerry challengestoandopportunitiesfortheadoptionandroutineuseofearlywarningindicatorstomonitorpediatrichivdrugresistanceinkenya
AT mathekajames challengestoandopportunitiesfortheadoptionandroutineuseofearlywarningindicatorstomonitorpediatrichivdrugresistanceinkenya
AT mukuiirene challengestoandopportunitiesfortheadoptionandroutineuseofearlywarningindicatorstomonitorpediatrichivdrugresistanceinkenya
AT kalibalasamuel challengestoandopportunitiesfortheadoptionandroutineuseofearlywarningindicatorstomonitorpediatrichivdrugresistanceinkenya